These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9434819)

  • 1. Hepatoblastoma incidence in the United States from 1973 to 1992.
    Ross JA; Gurney JG
    Med Pediatr Oncol; 1998 Mar; 30(3):141-2. PubMed ID: 9434819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoblastoma: why so many low-birth-weight infants?
    Slovis TL; Roebuck DJ
    Pediatr Radiol; 2006 Mar; 36(3):173-4. PubMed ID: 16456653
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends in incidence of childhood malignant solid tumors in Japan: Estimation based on hospital-based registration.
    Ikeda H; Nakamura Y
    J Pediatr Surg; 2015 Sep; 50(9):1506-12. PubMed ID: 25783293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoblastoma and low birth weight: a trend or chance observation?
    Feusner J; Plaschkes J
    Med Pediatr Oncol; 2002 Nov; 39(5):508-9. PubMed ID: 12228908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth characteristics and hepatoblastoma risk in young children.
    Reynolds P; Urayama KY; Von Behren J; Feusner J
    Cancer; 2004 Mar; 100(5):1070-6. PubMed ID: 14983504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal and infant birth characteristics and hepatoblastoma.
    McLaughlin CC; Baptiste MS; Schymura MJ; Nasca PC; Zdeb MS
    Am J Epidemiol; 2006 May; 163(9):818-28. PubMed ID: 16510543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoblastoma in the Nordic countries.
    de Fine Licht S; Schmidt LS; Rod NH; Schmiegelow K; Lähteenmäki PM; Kogner P; Träger C; Stokland T; Schüz J
    Int J Cancer; 2012 Aug; 131(4):E555-61. PubMed ID: 22095187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness Analysis of Screening Extremely Low Birth Weight Children for Hepatoblastoma Using Serum Alpha-fetoprotein.
    MacDonell-Yilmaz R; Anderson K; DeNardo B; Sprinz P; Padula WV
    J Pediatr; 2020 Oct; 225():80-89.e4. PubMed ID: 32470475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of hepatoblastoma among immature children with a lower birth weight.
    Tanimura M; Matsui I; Abe J; Ikeda H; Kobayashi N; Ohira M; Yokoyama M; Kaneko M
    Cancer Res; 1998 Jul; 58(14):3032-5. PubMed ID: 9679968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities.
    Cruz RJ; Ranganathan S; Mazariegos G; Soltys K; Nayyar N; Sun Q; Bond G; Shaw PH; Haberman K; Krishnamurti L; Marsh JW; Humar A; Sindhi R
    Surgery; 2013 Feb; 153(2):150-9. PubMed ID: 23331862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between hepatoblastoma and very low birth weight: a trend or a chance?
    Ikeda H; Matsuyama S; Tanimura M
    J Pediatr; 1997 Apr; 130(4):557-60. PubMed ID: 9108853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of primary hepatic malignancies in U.S. children.
    Darbari A; Sabin KM; Shapiro CN; Schwarz KB
    Hepatology; 2003 Sep; 38(3):560-6. PubMed ID: 12939582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence trends and survival prediction of hepatoblastoma in children: a population-based study.
    Feng J; Polychronidis G; Heger U; Frongia G; Mehrabi A; Hoffmann K
    Cancer Commun (Lond); 2019 Oct; 39(1):62. PubMed ID: 31651371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control study of birth characteristics and the risk of hepatoblastoma.
    Heck JE; Meyers TJ; Lombardi C; Park AS; Cockburn M; Reynolds P; Ritz B
    Cancer Epidemiol; 2013 Aug; 37(4):390-5. PubMed ID: 23558166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoblastoma and low birth weight.
    Spector LG; Feusner JH; Ross JA
    Pediatr Blood Cancer; 2004 Nov; 43(6):706. PubMed ID: 15390302
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatoblastoma incidence in Taiwan: A population-based study.
    Hung GY; Lin LY; Yu TY; Lee CY; Yen HJ; Horng JL
    J Chin Med Assoc; 2018 Jun; 81(6):541-547. PubMed ID: 29459224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retrospective analysis of maternal and infant birth features of hepatoblastoma patients].
    Pu CL; Guo CB; Jin XQ; Deng C; Zhang MM; Li YC; Kang Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):459-61. PubMed ID: 19567028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoblastoma in children of extremely low birth weight: a report from a single perinatal center.
    Oue T; Kubota A; Okuyama H; Kawahara H; Nara K; Kawa K; Kitajima H
    J Pediatr Surg; 2003 Jan; 38(1):134-7; discussion 134-7. PubMed ID: 12592636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal pregnancy events and exposures and risk of hepatoblastoma: a Children's Oncology Group (COG) study.
    Musselman JR; Georgieff MK; Ross JA; Tomlinson GE; Feusner J; Krailo M; Spector LG
    Cancer Epidemiol; 2013 Jun; 37(3):318-20. PubMed ID: 23312454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin receptor presence in hepatoblastoma: a possible link to increased incidence of hepatoblastoma in very low birthweight infants.
    Trobaugh-Lotrario AD; Greffe B; Garza-Williams S; Haas JE; Odom LF
    Pediatr Blood Cancer; 2007 Sep; 49(3):365-6. PubMed ID: 16937361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.